Skip to Content

Tag: Eversense


Also Noted

Ascensia launches Eversense 365

October 3, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care has launched its Eversense 365 continuous glucose monitoring system, which received clearance from the U.S. Food and Drug Administration in September. “Eversense offers a completely differentiated CGM experience, overcoming many of the frustrations experienced with traditional, short-term CGMs, such as early failure, disruptive false alerts and skin irritation,” said Brian Hansen, president of CGM at Ascensia. “With only one CGM replacement...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Eversense


Read Full Articlered right arrow icon

Also Noted

Ascensia receives iCGM designation for Eversense

May 1, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have received an integrated CGM designation from the U.S. Food and Drug Administration. The designation indicates that the Eversense iCGM product can integrate with compatible medical devices, including insulin pumps. “Managing diabetes is all about personal choice and finding the options that best support an individual to live a healthier, less interrupted life,” said Brian Hansen, president of CGM at Ascensia. “For...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Eversense


Read Full Articlered right arrow icon

E-SP

Health care goes OTC

April 26, 2024Theresa Flaherty, Managing Editor

As is par for the course these days, my inbox this month has been filled with diabetes tech announcements: Edgepark is adding a new insulin delivery system to its portfolio, Insulet’s Omnipod is fueling growth and Ascensia is expanding access to its Eversense device by extending its PASS program, which offers a substantial discount for users.  That last one is key: All the technology in the world won’t help if it’s too expensive for people to acquire. And this stuff is expensive...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Diabetes, Eversense, Omnipod


Read Full Articlered right arrow icon

Also Noted

Ascensia extends PASS program

March 14, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings will extend the Eversense Payment Assistance and Simple Savings (PASS) Program. Designed to help people in the U.S. access the Eversense E3 CGM System more affordably, the program offers major savings for eligible individuals looking to experience the unique benefits of the only long-term CGM system available. Eligible individuals will pay only $99 out of pocket for an unlimited number of six-month Eversense E3 systems under...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Diabetes, Eversense, Senseonics


Read Full Articlered right arrow icon

Also Noted

Ascensia announces coverage expansion for CGM system 

February 12, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of local coverage determinations that provide access to implantable CGM for basal-only patients. Medicare coverage has been expanded for implantable CGMs to include all people with diabetes using insulin, removing the previous requirement for multiple inulin administrations per day. Coverage has also been updated...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Eversense, Senseonics


Read Full Articlered right arrow icon

Ascensia: ‘This is Diabetes, This is Real’ 

Also Noted

Ascensia: ‘This is Diabetes, This is Real’ 

September 19, 2023HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care, owner of the CONTOUR blood glucose monitoring system portfolio and exclusive distributor of the Eversense continuous glucose monitoring system, has opened submissions for its art and photo competition in support of World Diabetes Day 2023. The theme of this year’s competition is “This is Diabetes, This is Real,” aiming to capture the challenges, successes and day-to-day realities of people living with diabetes. “For our 2023...

Ascensia Diabetes Care, Blood Glucose Monitor, Continuous Glucose Monitor (CGM), CONTOUR, Diabetes, Eversense, World Diabetes Day


Read Full Articlered right arrow icon

News

In brief: Medline’s new leadership, AAH’s lobby day, women’s sleep quality

June 30, 2023HME News Staff

NORTHFIELD, Ill. – Medline CEO Charlie Mills, President Andy Mills and COO Jim Abrams plan to retire from their current roles after more than 26 years of leadership.  They will continue to serve on the company’s board of directors, with Charlie Mills leading as chairman and Andy Mills and Jim Abrams as vice chairmen.  Medline has promoted Jim Boyle to serve as its next CEO, and Jim Pigott as president & COO, effective Oct. 1, culminating a five-year succession planning...

AAHomecare, Diabetes, Eversense, McKesson, Medline, Sleep


Read Full Articlered right arrow icon

Also Noted

Senseonics’ Eversense E3 offers accurate 365-day performance

June 28, 2023HME News Staff

GERMANTOWN, Md. – Senseonics Holdings highlighted new clinical data demonstrating the safety and accuracy of its Eversense E3 CGM system during a presentation at the American Diabetes Association 83rd Scientific Session. “These data further bolster Eversense’s position as a leading CGM choice for people with diabetes,” said Francine Kaufman, M.D., Senseonics chief medical officer. “These recent studies are an important step forward as we continue to expand awareness...

Continuous Glucose Monitor (CGM), Eversense, Senseonics


Read Full Articlered right arrow icon

Also Noted

Senseonics secures coverage from UnitedHealthcare 

June 5, 2023HME News Staff

GERMANTOWN, Md. – Senseonics Holdings has announced that UnitedHealthcare will begin providing coverage for the Eversense E3 CGM System effective July 1, 2023, for people with Type 1 and insulin-requiring Type 2 diabetes. "The policy update from UnitedHealthcare marks an important milestone for increased access to long-term CGM for people with diabetes,” said Tim Goodnow, PhD, president and CEO for Senseonics. “With the addition of UnitedHealthcare, we are nearing all insured adults...

Continuous Glucose Monitor (CGM), Eversense, Senseonics, UnitedHealthcare


Read Full Articlered right arrow icon

News

In brief: Viemed acquisition, Philips recall, Quipt public offering

April 21, 2023HME News Staff

LAFAYETTE, La., - Viemed Healthcare will acquire Tennessee based Home Medical Products, a large regional provider of respiratory focused home medical solutions.  “We are incredibly excited to complement our strong history of organic growth by combining great teams through accretive transactions” said Casey Hoyt, Viemed CEO. “The purchase of HMP will launch our acquisition growth initiatives with a stellar organization that has an extraordinary reputation with patients, payors...

1800wheelchair, Diabetes, Eversense, National Community Pharmacists Association (NCPA), National Registry of Rehabilitation Technology Suppliers (NRRTS), PAMES, Philips Recall, Quipt, Viemed Healthcare


Read Full Articlered right arrow icon